ATS Comments and Testimony
ATS Comments on the Affordable Care Act
- March 2018 ATS Comments on Association Health Plans
- November 2017 Comments on ACA Insurance Standards
- ATS Letter Urging Congress to Maintain Insurance Coverage in ACA Repeal and Replace Efforts
- ATS Comments on the ACA Essential Health Benefits Package
- ATS Comments on ACA Medicaid Expansion
ATS Health Policy Committee Commentaries
Congress and Courts
- 3/28/24 U.S. v Idaho ATS amicus brief in support of EMTALA protections for emergency access to abortion services
- 3/22/24 Held v Montana ATS amicus brief in support of Montana state obligation to address climate change
- 2/2/24 FDA v Alliance for Hippocratic Medicine ATS amicus brief in support of access to mifepristone
- 5/11/23 Braidwood Management v Becerra AMA, ATS et al amicus brief in support of USPSTF preventive benefits
- 3/3/23: ATS amicus brief in Texas v EPA submitted to the U.S. District Court of Appeals District of Columbia in support of EPA & California's authority to regulate vehicle tailpipe emissions.
- 11/14/2018: Letter to Congress supporting ACE Kids Act
- 07/17/2018: ATS Amicus Brief - AAP v FDA E-cigarettes
- 04/26/2018: ATS Testimony to House Labor-HHS Appropriations Subcommittee on NIH and CDC Programs
- 12/15/2017: ATS Letter on Final Tax Bill
- 12/13/2017: ATS Letter on CHIP Funding Reauthorization
- 12/01/2017: Letter Supporting CDC Chronic Disease Funding
- 04/07/2017: U.S. House of Representative NIH Letter and List of Signors
- 04/01/2016: ATS Amicus Brief - WV v EPA Clean Power Plan 2016
- 01/27/2016: ATS Recommendations to the U.S. Senate Finance Committee in response to Bipartisan Chronic Care Working Group's Policy Options Document
- 03/01/2013: ATS Testimony to the House State, Foreign Ops & Related Agencies Approps. Sub. Comm. on the TB Program FY2014 Funding
- 03/23/2011: ATS Testimony before the House Mil/Con/VA Appropriations Subcommittee on VA Research Funding
Congressional Letters
- September 2021 Letter to Reps Nadler and Lofgren on foreign-born STEM students
- May 2021 Ad Hoc Group for Medical Research Letter Urging Funding for Research
- ATS Letter to Congress on 2021 Health Program Priorities
- August 2020 Letter to Congress Supporting Pediatric Education Incentives
- NHLBI Constituency Group letter to Congress supporting NHLBI COVID-19 Research Funding
- May 2020 Letter to Congress Requesting Financial Relief for Pediatric Providers
- 2019 Senate Domestic TB Appropriations Letter
- Letter to Congress Supporting PCORI Renewal
Federal Agencies
- 10/03/2022: ATS Comments on Section 1557
- 05/24/2021: ATS Comments on Justice40 Initiative
- 04/22/2021: ATS Comments to NIH on Racial Equity
- 01/20/2021: ATS Comments to USPSTF on Sleep Apnea Screening
- 12/07/2020: ATS Comments on NIH COVID Research Strategic Plan
- 10/26/2020: Letter to ICE on J-1 International Medical Graduates Proposed Rule
- 07/31/2020: ATS Comments on NIGMS Strategic Plan Framework
- 06/01/2020: ATS Comments on NIOSH World Trade Center Research Program
- 07/31/2020: ATS Comment to NIH Fetal Tissue Research Ethics Panel
- 04/08/2020: S-Far Letter to CDC on Secondary Infections and Antibiotic Resistance
- 12/21/2018: Letter to HHS Secretary Supporting Fetal Tissue Research
- 12/10/2018: Jonathan Samet MD MS and colleagues – Proposed Changes to CASAC Review Process
- 12/07/2018: ATS Comments on Public Charge Determinations (Immigrant Health)
- 08/31/2018: ATS Comments to NIGMS on Accelerating Sepsis Research
- 08/10/2018: ATS Comments on Asbestos; Significant New Use Rule
- 07/16/2018: ATS Comments on Trump Administration Drug Pricing Blueprint
- 12/14/2017: December 2017 thanking FDA for Stem Cell Therapeutics
- 09/02/2014: ATS comment to CMS on 2015 Medicare Physician Fee Schedule
- 09/02/2014: ATS comments to CMS on 2015 Hospital Outpatient Prospective Payments
- 08/31/2012: ATS Comments on Medicare Programs: Revisions to Payment Policies Under Physician Fee Schedule
- 02/17/2012: ATS Comments on the proposed rules of section 6002 of the Affordable Care Act (ACA)
- 11/23/2011: ATS Comments to EPA on Primatene Mist Phase-Out
- 10/31/2011: ATS Comments Filed with DOT on Smoking of Electronic Cigarettes on Aircraft
- 09/26/2011: ATS Comments to CMS on Health Insurance Exchanges
- 08/26/2011: ATS Comments to CMS on the Proposed 2012 Medicare Physician Fee Schedule
- 06/06/2011: ATS Comments to CMS on the Creation of Accountable Care Organizations
- 06/06/2011: ATS Comments to CMS on the creation of Accountable Care Organizations (ACO)'s
Medicaid
Other Public Comments
- 08/23/2021: ATS signs onto letter supporting mask extension mandate on public transportation
- 03/19/21: ATS letter to State Dental Boards
- 12/09/2020: ATS Opposes EPA's Final Cost Benefit Rule
- 12/08/2020: Statement Against EPA Decision to Retain Current Particulate Matter Exposure Standard
- Federal Diversity Training Changes Letter to the Director of
Office of Management and Budget, Executive Office of the President - Responding to the Recent Executive Order Mandating How to Address Race and Diversity
- 09/24/2020: Statement in Support of Anti-Racist Education
- March 2018 AHRQ Annual Funding Letter
- Letter to Department of Transportation regarding withdrawl of Sleep Apnea Screening
- Ad Hoc Group for Medical Research Letter on 2017 NIH Funding
- Joint Internal Medicine Letter Opposing Immigration Ban
- Coalition Letters Opposing House and Senate FY 2016 AHRQ Funding Cuts
- ATS Policy Brief on Clean Air
- Statement on EPA's Power Plant Air Toxics Rule
- ATS letter to Joint Committee on Deficit Reduction Committee
- Comment on OHRP Proposed Revisions to Human Research Protections
